Home Journals Subjects About My LA Reviewers Authors News Submit
Username: Password:
.
(close)

(Ctrl-click to select multiple journals)

How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement
 
 
 

Drug Target Insights

Synopsis: An open access, peer reviewed electronic journal that covers drug treatment targets.

Indexing: 6 major databases. Pubmed indexing for NIH-funded research.

Processing time: Decision in 2 weeks for 90% of papers.

Latest news:

Thousands of article downloads per month. 

Click for the latest open access visibility statistics.

View factor:
Journal: 105371
Most read article: 2479
Editor in chief:
Monica Milani
Editorial Board
ISSN: 1177-3928


 
 
 

Drug Target Insights call for papers from Dr Monica Milani


Dear colleagues,

I would like to invite you to submit a paper to Drug Target Insights – one of the most successful journals published by Libertas Academica, with a view factor of more than 70,000.

Drug Target Insights welcomes manuscripts reporting original and unpublished research regarding any aspect of the field of clinical therapeutics. More specifically, topics can range from the description molecular drug targets to the patients’ perspective on a particular therapeutic treatment. There is no restriction on the pathology under study.

All papers will be refereed within a peer-review system. Reviewers are experts in the field and will provide comments in a timely manner. Your paper will be indexed by the following databases: Embase, Google scholar, CAS, and DOAJ. Most importantly, in the event that your research is NIH funded, your paper will be also added to the Pubmed database.

Getting your paper published in an open access journal, such as Drug Target Insights, will benefit both you and the scientific community. You will benefit by making your research visible to the widest possible scientific audience. The scientific community will benefit from the fact that anyone will be able to learn about the latest discoveries in the field at no cost. When information is available to everybody, progress proceeds at the fastest pace.

In short, publishing in Drug Target Insights provides you with the following advantages:
  • Full open access: everyone can read your article and you retain copyright in it
  • Publishing decision within 2 weeks of submission
  • Your paper will not be rejected due to lack of space and will be published immediately on acceptance
  • Prompt and fair peer review from two expert peer reviewers
  • Frequent updates on your paper’s status
  • Friendly responsive staff
Aims and scope:

Drug Target Insights is a journal that publishes papers in all areas of drug treatment targets.

What a previous author said:
"I would like to say that this is the most author-friendly editing process I have experienced in over 150 publications. Thank you most sincerely."

In summary:

The advantages of a younger journal such as Drug Target Insights are numerous but in essence allow us a greater flexibility and responsiveness to authors and readers that older journals cannot match.

Yours sincerely,
Dr Monica Milani

Editor-in-Chief
Drug Target Insights

Our article visibility statistics                What your colleagues say about us

 




 
 
 

Drug Target Insights


Monica Milani, Editor in Chief


 New article RSS feed  Journal newsletter

Submit a paper

 
 
 


Copyright and privacy policy| About us| Tell us how we're doing